Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Clonidine 100microgram tablets
0205020E0AAACAC
|
Clonidine hydrochloride (Vasodilator) | Clonidine hydrochloride | Cardiovascular System | 18,870 |
|
Clonidine 300micrograms/24hours transdermal patches
0205020E0AAAHAH
|
Clonidine hydrochloride (Vasodilator) | Clonidine hydrochloride | Cardiovascular System | 185 |
|
Clonidine 100micrograms/24hours transdermal patches
0205020E0AAAFAF
|
Clonidine hydrochloride (Vasodilator) | Clonidine hydrochloride | Cardiovascular System | 129 |
|
Clonidine 200micrograms/24hours transdermal patches
0205020E0AAAGAG
|
Clonidine hydrochloride (Vasodilator) | Clonidine hydrochloride | Cardiovascular System | 86 |
|
Clonidine 150micrograms/1ml solution for injection ampoules
0205020E0AAABAB
|
Clonidine hydrochloride (Vasodilator) | Clonidine hydrochloride | Cardiovascular System | 67 |
|
Clonidine 250microgram modified-release capsules
0205020E0AAAAAA
|
Clonidine hydrochloride (Vasodilator) | Clonidine hydrochloride | Cardiovascular System | No data available |
|
Clonidine 300microgram tablets
0205020E0AAADAD
|
Clonidine hydrochloride (Vasodilator) | Clonidine hydrochloride | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.